These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 30242966)

  • 1. Modeling pharmaceutical emissions and their toxicity-related effects in life cycle assessment (LCA): A review.
    Emara Y; Lehmann A; Siegert MW; Finkbeiner M
    Integr Environ Assess Manag; 2019 Jan; 15(1):6-18. PubMed ID: 30242966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential ecotoxicological impact of pharmaceutical and personal care products on humans and freshwater, based on USEtox™ characterization factors. A Spanish case study of toxicity impact scores.
    Ortiz de García S; García-Encina PA; Irusta-Mata R
    Sci Total Environ; 2017 Dec; 609():429-445. PubMed ID: 28755593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prioritization of pharmaceuticals based on risks to aquatic environments in Kazakhstan.
    Aubakirova B; Beisenova R; Boxall AB
    Integr Environ Assess Manag; 2017 Sep; 13(5):832-839. PubMed ID: 28120523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bridging the gap between life cycle inventory and impact assessment for toxicological assessments of pesticides used in crop production.
    van Zelm R; Larrey-Lassalle P; Roux P
    Chemosphere; 2014 Apr; 100():175-81. PubMed ID: 24314898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of life cycle toxicity assessment methods for municipal wastewater treatment with the inclusion of direct emissions of metals, PPCPs and EDCs.
    Rashid SS; Liu YQ
    Sci Total Environ; 2021 Feb; 756():143849. PubMed ID: 33248794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring REACH as a potential data source for characterizing ecotoxicity in life cycle assessment.
    Müller N; de Zwart D; Hauschild M; Kijko G; Fantke P
    Environ Toxicol Chem; 2017 Feb; 36(2):492-500. PubMed ID: 27355758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving substance information in USEtox
    Saouter E; Aschberger K; Fantke P; Hauschild MZ; Bopp SK; Kienzler A; Paini A; Pant R; Secchi M; Sala S
    Environ Toxicol Chem; 2017 Dec; 36(12):3450-3462. PubMed ID: 28618056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limitations of toxicity characterization in life cycle assessment: Can adverse outcome pathways provide a new foundation?
    Gust KA; Collier ZA; Mayo ML; Stanley JK; Gong P; Chappell MA
    Integr Environ Assess Manag; 2016 Jul; 12(3):580-90. PubMed ID: 26331849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating site-specific dispersion modeling into life cycle assessment, with a focus on inhalation risks in chemical production.
    Tian S; Bilec M
    J Air Waste Manag Assoc; 2018 Nov; 68(11):1224-1238. PubMed ID: 29985784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of different life-cycle impact assessment methods for aquatic ecotoxicity.
    Schulze C; Jödicke A; Scheringer M; Margni M; Jolliet O; Hungerbühler K; Matthies M
    Environ Toxicol Chem; 2001 Sep; 20(9):2122-32. PubMed ID: 11521844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prioritising pharmaceuticals for environmental risk assessment: Towards adequate and feasible first-tier selection.
    Roos V; Gunnarsson L; Fick J; Larsson DG; Rudén C
    Sci Total Environ; 2012 Apr; 421-422():102-10. PubMed ID: 22361586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Handling uncertainties inherited in life cycle inventory and life cycle impact assessment method for improved life cycle assessment of wastewater sludge treatment.
    Alyaseri I; Zhou J
    Heliyon; 2019 Nov; 5(11):e02793. PubMed ID: 31844724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceuticals in water, fish and osprey nestlings in Delaware River and Bay.
    Bean TG; Rattner BA; Lazarus RS; Day DD; Burket SR; Brooks BW; Haddad SP; Bowerman WW
    Environ Pollut; 2018 Jan; 232():533-545. PubMed ID: 29032907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of metabolites in the environmental risk assessment of pharmaceuticals consumed by human.
    Han EJ; Lee DS
    Sci Total Environ; 2017 Aug; 592():600-607. PubMed ID: 28318699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ranking potential impacts of priority and emerging pollutants in urban wastewater through life cycle impact assessment.
    Muñoz I; José Gómez M; Molina-Díaz A; Huijbregts MA; Fernández-Alba AR; García-Calvo E
    Chemosphere; 2008 Dec; 74(1):37-44. PubMed ID: 18951608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total environmental impacts of biofuels from corn stover using a hybrid life cycle assessment model combining process life cycle assessment and economic input-output life cycle assessment.
    Liu C; Huang Y; Wang X; Tai Y; Liu L; Liu H
    Integr Environ Assess Manag; 2018 Jan; 14(1):139-149. PubMed ID: 28796442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prioritizing pharmaceuticals based on environmental risks in the aquatic environment in China.
    Guo J; Liu S; Zhou L; Cheng B; Li Q
    J Environ Manage; 2021 Jan; 278(Pt 1):111479. PubMed ID: 33126192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Priority screening of toxic chemicals and industry sectors in the U.S. toxics release inventory: a comparison of the life cycle impact-based and risk-based assessment tools developed by U.S. EPA.
    Lim SR; Lam CW; Schoenung JM
    J Environ Manage; 2011 Sep; 92(9):2235-40. PubMed ID: 21561706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward harmonizing ecotoxicity characterization in life cycle impact assessment.
    Fantke P; Aurisano N; Bare J; Backhaus T; Bulle C; Chapman PM; De Zwart D; Dwyer R; Ernstoff A; Golsteijn L; Holmquist H; Jolliet O; McKone TE; Owsianiak M; Peijnenburg W; Posthuma L; Roos S; Saouter E; Schowanek D; van Straalen NM; Vijver MG; Hauschild M
    Environ Toxicol Chem; 2018 Dec; 37(12):2955-2971. PubMed ID: 30178491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risks associated with the environmental release of pharmaceuticals on the U.S. Food and Drug Administration "flush list".
    Khan U; Bloom RA; Nicell JA; Laurenson JP
    Sci Total Environ; 2017 Dec; 609():1023-1040. PubMed ID: 28787777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.